|
Name |
2-(4-Hydroxyphenyl)ethanol
|
Molecular Formula | C8H10O2 | |
IUPAC Name* |
4-(2-hydroxyethyl)phenol
|
|
SMILES |
C1=CC(=CC=C1CCO)O
|
|
InChI |
InChI=1S/C8H10O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,9-10H,5-6H2
|
|
InChIKey |
YCCILVSKPBXVIP-UHFFFAOYSA-N
|
|
Synonyms |
2-(4-Hydroxyphenyl)ethanol; Tyrosol; 501-94-0; 4-Hydroxyphenethyl alcohol; 4-(2-Hydroxyethyl)phenol; 4-Hydroxyphenylethanol; 4-Hydroxybenzeneethanol; p-Hydroxyphenethyl alcohol; Benzeneethanol, 4-hydroxy-; p-Tyrosol; 4-Hydroxyphenylethyl alcohol; 2-(4-Hydroxyphenyl)ethyl Alcohol; p-Thyrosol; MFCD00002902; NSC 59876; 2-(P-HYDROXYPHENYL)ETHANOL; Metoprolol IMpurity 07; 4-hydroxy-Benzeneethanol; 1AK4MU3SNX; p-Hydroxyphenylethyl alcohol; 4-(2-Hydroxy-ethyl)-phenol; CHEMBL53566; CHEBI:1879; NSC-59876; p-hydroxyphenylethanol; Tyrosol C; SMR000857159; p-HPEA; 4-hydroxyphenethylalcohol; EINECS 207-930-8; UNII-1AK4MU3SNX; beta-(4-Hydroxyphenyl)ethanol; 4-tyrosol; YRL; Tyrosol ,(S); 4-hydroxybenzenethanol; 4-(Hydroxyethyl)phenol; p-Hydroxy-benzeneethanol; TYROSOL [MI]; b-(p-Hydroxyphenyl)ethanol; bmse000173; b-(4-Hydroxyphenyl)ethanol; 4-Hydroxyphenylmethylcarbinol; 2-(p-hydroxyphenyl) ethanol; SCHEMBL43838; (4-Hydroxyphenethyl) alcohol; 2-(4-hydroxyphenyl) ethanol; 2-(4-hydroxyphenyl)-ethanol; beta-(p-Hydroxyphenyl)ethanol; MLS001332423; MLS001332424; Phenethyl alcohol, p-hydroxy-; Ethanol, 2-(4-hydroxyphenyl); DTXSID8060111; SCHEMBL10620528; .beta.-(p-Hydroxyphenyl)ethanol; 2-(4-Hydroxyphenyl)-1-ethanol; Ethanol, 2-(4-hydroxyphenyl)-; .beta.-(4-Hydroxyphenyl)ethanol; HMS2230E12; ZINC164581; 2-(4-Hydroxyphenyl)ethanol, 98%; BCP34277; HY-N0474; NSC59876; STR02735; HYDROXYPHENETHYL ALCOHOL, P-; BDBM50339585; s3773; AKOS000280287; AC-2493; CCG-266147; CS-W019782; KS-5274; NCGC00246994-01; SY001653; DB-019455; AM20060146; FT-0608647; H0720; A14486; C06044; EN300-116733; 2-(4-Hydroxyphenyl)ethanol, analytical standard; NSC 59876; p-HPEA;4-Hydroxyphenethyl alcohol; Q402607; METOPROLOL TARTRATE IMPURITY G [EP IMPURITY]; METOPROLOL SUCCINATE IMPURITY G [EP IMPURITY]; TYROSOL (CONSTITUENT OF RHODIOLA ROSEA) [DSC]; F0001-1309; Z1250886919; 947D0361-23C6-4863-8346-22AB05108AC5; 4-hydroxy-Benzeneethanol;4-Hydroxyphenylethanol;beta-(4-Hydroxyphenyl)ethanol
|
|
CAS | 501-94-0 | |
PubChem CID | 10393 | |
ChEMBL ID | CHEMBL53566 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 138.16 | ALogp: | 0.4 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.647 |
Caco-2 Permeability: | -4.252 | MDCK Permeability: | 0.00001650 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.122 | 20% Bioavailability (F20%): | 0.986 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.128 | Plasma Protein Binding (PPB): | 32.60% |
Volume Distribution (VD): | 3.17 | Fu: | 62.37% |
CYP1A2-inhibitor: | 0.512 | CYP1A2-substrate: | 0.375 |
CYP2C19-inhibitor: | 0.245 | CYP2C19-substrate: | 0.251 |
CYP2C9-inhibitor: | 0.056 | CYP2C9-substrate: | 0.791 |
CYP2D6-inhibitor: | 0.116 | CYP2D6-substrate: | 0.638 |
CYP3A4-inhibitor: | 0.045 | CYP3A4-substrate: | 0.288 |
Clearance (CL): | 13.4 | Half-life (T1/2): | 0.881 |
hERG Blockers: | 0.038 | Human Hepatotoxicity (H-HT): | 0.048 |
Drug-inuced Liver Injury (DILI): | 0.035 | AMES Toxicity: | 0.103 |
Rat Oral Acute Toxicity: | 0.337 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.87 | Carcinogencity: | 0.607 |
Eye Corrosion: | 0.92 | Eye Irritation: | 0.993 |
Respiratory Toxicity: | 0.038 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006122 | 0.600 | D03UOT | 0.515 | ||||
ENC000006 | 0.568 | D0W1RY | 0.513 | ||||
ENC000870 | 0.561 | D01CRB | 0.500 | ||||
ENC001422 | 0.561 | D0B3QM | 0.477 | ||||
ENC000740 | 0.556 | D0S2BV | 0.400 | ||||
ENC000676 | 0.556 | D00LFB | 0.381 | ||||
ENC000756 | 0.556 | D0U5QK | 0.381 | ||||
ENC005811 | 0.533 | D0J7RK | 0.364 | ||||
ENC005812 | 0.533 | D0T7OW | 0.349 | ||||
ENC000774 | 0.526 | D06KYN | 0.348 |